Financial Advisors Network, Inc. Vertex Pharmaceuticals Inc Transaction History

Financial Advisors Network, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Jun 04, 2019	SELL	$163.73 - $194.7 $1.02 Million - $1.22 Million	-6,247 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $42,230 - $53,434	278 Added 4.66%	6,247 $1.04 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $869,802 - $1.01 Million	5,969 New	5,969 $1.01 Million

1,724

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Financial Advisors Network, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Advisors Network, Inc. with notifications on news.